These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6879128)

  • 1. [Significance of hormone receptors in the therapy of breast cancer].
    Obrist R; Obrecht JP
    Schweiz Med Wochenschr; 1983 May; 113(20):749-53. PubMed ID: 6879128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between estrogen and progesterone receptors and response to hormone therapy].
    Leclercq G; Paridaens R; Heuson JC
    Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of adjuvant endocrine therapy for breast cancer.
    Ingle JN
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4392s-4396s; discussion 4411s-4412s. PubMed ID: 11916230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective mechanisms of hormonal therapy].
    Stoll BA
    Vopr Onkol; 1979; 25(5):67-75. PubMed ID: 380153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
    Mortimer J; Reimer R; Greenstreet R; Groppe C; Bukowski R
    Cancer Treat Rep; 1981; 65(9-10):763-6. PubMed ID: 7273011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tissue estrogen receptors in the strategy of breast cancer treatment.
    Heuson JC; Leclercq G
    Arch Geschwulstforsch; 1975; 45(5):417-22. PubMed ID: 174515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
    Ellis MJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to reverse resistance to hormonal therapy in human breast cancer.
    Weinberg OK; Marquez-Garban DC; Pietras RJ
    Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods.
    McCarty KS; Hiatt KB; Budwit DA; Cox EB; Leight G; Reintgen D; Georgiade G; McCarty KS; Siegler HF
    Arch Pathol Lab Med; 1984 Jan; 108(1):24-6. PubMed ID: 6546332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the endocrine treatment of breast cancer.
    Stoll BA
    Eur J Cancer (1965); 1980; Suppl 1():79-80. PubMed ID: 7318874
    [No Abstract]   [Full Text] [Related]  

  • 14. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.
    McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():39-43. PubMed ID: 7032943
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy of breast cancer.
    Bonadonna G
    Br J Hosp Med; 1980 Jan; 23(1):40, 45, 48 passim. PubMed ID: 6986934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contribution of estrogen receptors in the therapeutic strategy of breast cancer].
    Paridaens R; Sylvester R; Ferrazzi E; Legros N; Leclercq G; Heuson JC
    Gynakol Rundsch; 1981; 21 Suppl 1():87-100. PubMed ID: 7239346
    [No Abstract]   [Full Text] [Related]  

  • 18. Aromatase inhibitors in breast cancer: an overview.
    Altundag K; Ibrahim NK
    Oncologist; 2006 Jun; 11(6):553-62. PubMed ID: 16794235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormones and tumor therapy: the rational basis of endocrine therapy in breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):459-63. PubMed ID: 6297173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatment.
    Salmon RJ; Alran S; Malka I; de Cremoux P; Rosty C; Languille O; Campana F; ; Sigal-Zafrani B
    Am J Clin Oncol; 2006 Aug; 29(4):385-8. PubMed ID: 16891867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.